Patient Guide: Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 28 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05070845
Status: 🟢 Enrolling Now
Condition: Primary Immune Thrombocytopenia
Phase: PHASE2

Where You Can Participate

This study is available at 28 locations across the country.

Top locations include:
  • • Greenville, North Carolina
  • • Kogarah, New South Wales
  • • Liverpool, New South Wales
  • • And 25 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia - Join Clinical Trial NCTNCT05070845

How to Join This Clinical Trial - NCTNCT05070845

Learn how to participate in this PHASE2 trial studying an investigational therapy for Primary Immune Thrombocytopenia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Primary Immune Thrombocytopenia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Primary Immune Thrombocytopenia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05070845 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 28 locations. Find a study site near you:

Clinical Research Site

Greenville, North Carolina 27834 - United States

Status: RECRUITING

Clinical Research Site

Kogarah, New South Wales 2217 - Australia

Status: RECRUITING

Clinical Research Site

Liverpool, New South Wales 2170 - Australia

Status: RECRUITING

Clinical Research Site

Liverpool, New South Wales 2170 - Australia

Status: RECRUITING

Clinical Research Site

Mount Kuring-Gai, New South Wales 2080 - Australia

Status: RECRUITING

Clinical Research Site

Waratah, New South Wales 2298 - Australia

Status: RECRUITING

Clinical Research Site

Bedford Park, South Australia 5042 - Australia

Status: RECRUITING

Clinical Research Site

Kurralta Park, South Australia 5037 - Australia

Status: RECRUITING

Clinical Research Site

Melbourne, Victoria 3004 - Australia

Status: RECRUITING

Clinical Research Site

Perth, Western Australia 6000 - Australia

Status: RECRUITING

And 18 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Primary Immune Thrombocytopenia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships